TDK Ventures backs MEMS-based genome editing tools company, Mekonos

SAN JOSE, Calif.: SAN JOSE, Calif. , Nov. 9, 2021 /PRNewswire/ -- TDK Corporation (TSE: 6762) announced today that subsidiary TDK Ventures, Inc., has invested in biotech tools company Mekonos to accelerate the development and deployment of Mekonos' integrated molecular delivery chip, which brings much needed scaling and single-cell precision...

Click to view original post